Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)
$60.42
+1.1600 ( +1.96% ) 341.9K
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company'sĀ development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Market Data
Open
$60.42
Previous close
$59.26
Volume
341.9K
Market cap
$644.19M
Day range
$58.82 - $61.08
52 week range
$3.03 - $61.08
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 71 | Nov 14, 2023 |
8-k | 8K-related | 12 | Nov 13, 2023 |
10-q | Quarterly Reports | 80 | Nov 07, 2023 |
8-k | 8K-related | 13 | Nov 07, 2023 |
8-k | 8K-related | 13 | Aug 08, 2023 |
10-q | Quarterly Reports | 80 | Aug 08, 2023 |
8-k | 8K-related | 59 | Aug 03, 2023 |